Jefferies Cuts Price Target on Adeptus Health (ADPT) Following 2Q Report; Reiterates Buy
Jefferies maintained a Buy rating on Adeptus Health (NYSE: ADPT), and cut the price target to $100.00 (from $113.00), following ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
